Skip to main content
Caplight Logo









Twig Bio

Twig Bio

Private
LondonHealthcare & Life Scienceshttps://twig.bio/

Last Round

Grant

Apr 16, 2026

Total Funding Raised

$5.3M

Company Overview

Twig Bio is a bioengineering company that utilizes an AI-first approach to develop sustainable, eco-friendly alternatives to ingredients used in everyday consumer goods.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Revenue Share

AI Layer

Application

Keywords

cell engineeringsynthetic biologybioengineeringregenerative medicinedrug discoverybio-designhigh-throughput screeningfoundryAI-driven biologyfermentationstrain engineeringbiotech platformdry labwet lab automationfoundation model

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Twig Bio Comparables

Compare Twig Bio with similar companies based on industry and business-model similarity.

Twig Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Levprot Bioscience
67%
Tailwind Biotech
67%
Eden Bio
67%

Twig Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantApr 16, 2026
GrantJul 1, 2025
GrantMar 21, 2025
GrantFeb 14, 2024
SeedSep 11, 2023

Key People

Founding team and executive leadership

Satnam Surae

Co-founder and CTO

Founding Team

Russ Tucker

Co-Founder And CEO

Founding Team

Twig Bio Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 22, 2026

    Announced CANOPY, a foundation model for AI-driven strain design.

  • Jul 1, 2025

    $590K grant received from Innovate UK.

Twig Bio Filings

Explore SEC and related filing metadata, where available.

Twig Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Twig Bio's valuation, stock price, and market status.

Is Twig Bio a public or private company?

Twig Bio is a private company.

What is the current stock price of Twig Bio?

Twig Bio is a private company, so its shares have no public market price. Caplight tracks Twig Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Twig Bio worth (valuation)?

Valuation information for Twig Bio is not publicly available.

Can I buy Twig Bio stock?

Twig Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Twig Bio's last funding round?

Twig Bio's most recent funding round was Grant on April 16, 2026.

Who are the main investors in Twig Bio?

Key investors in Twig Bio include Innovate UK.

Will Twig Bio IPO soon?

No public IPO plans have been announced for Twig Bio.

How can I track Twig Bio secondary market activity?

Caplight tracks bids, offers, and trades in Twig Bio's shares on secondary markets.

Firmographic Details

HeadquartersLondon
Employee Range10
Year Founded2022
Last FundingApr 16, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?